Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 34 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10730842

    Small molecule inhibitors of DYRK1A and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  2. US 10724026

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  3. US 10722487

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  4. US 10722573

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  5. US 10723764

    Anti-microbial peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  6. US 10723778

    Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  7. US 10722550

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  8. US 10716856

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  9. US 10709758

    Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin

    The Board of Regents of the University of Oklahoma · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  10. US 10703721

    Caffeic acid derivatives and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  11. US 10703698

    Compounds which activate estrogen receptors and compositions and methods of using the same

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  12. US 10703805

    Molecular imprinting of West Nile antibodies with physiological pH matching

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  13. US 10696710

    Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

    The Board of Regents of the University of Texas System · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  14. US 10687520

    Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44

    The Board of Regents of the University of Texas System · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  15. US 10688203

    Methods of performing brachytherapy

    The Board of Regents of the University of Texas System · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  16. US 10683330

    Campylobacter immunogenic compositions and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  17. US 10683366

    Methods and compositions for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  18. US 10682388

    Targeting of PELP1 in cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  19. US 10682339

    Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  20. US 10669516

    Methods and apparatus for conditioning cell populations for cell therapies

    The Board of Regents of the University of Texas System · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  21. US 10668085

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  22. US 10661095

    Photodynamic therapy for use in treating cancer

    The Board of Regents of the University of Texas System · Granted May 26, 2020 · Expires May 21, 2040

    granted

  23. US 10660850

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted May 26, 2020 · Expires May 21, 2040

    granted

  24. US 10655183

    Carcinoma diagnosis and treatment based on ODC1 genotype

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 19, 2020 · Expires May 14, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.